Comparison of Three Different FDA-Approved Plasma HIV-1 RNA Assay Platforms Confirms the Virologic Failure Endpoint of 200 Copies Per Milliliter Despite Improved Assay Sensitivity
Journal of Clinical Microbiology - United States
doi 10.1128/jcm.00801-15
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 10, 2015
Authors
Publisher
American Society for Microbiology